Cargando…

rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy

X-linked myotubular myopathy (XLMTM) is a life-threatening skeletal muscle disease caused by mutations in the MTM1 gene. XLMTM fibres display a population of nuclei mispositioned in the centre. In the present study, we aimed to explore whether positioning and overall distribution of nuclei affects c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Jacob A., Tasfaout, Hichem, Levy, Yotam, Morgan, Jennifer, Cowling, Belinda S., Laporte, Jocelyn, Zanoteli, Edmar, Romero, Norma B., Lowe, Dawn A., Jungbluth, Heinz, Lawlor, Michael W., Mack, David L., Ochala, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574461/ https://www.ncbi.nlm.nih.gov/pubmed/33076971 http://dx.doi.org/10.1186/s40478-020-01048-8

Ejemplares similares

Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008)

Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice
por: Tasfaout, Hichem, et al.
Publicado: (2017)

Centronuclear myopathies under attack: A plethora of therapeutic targets
por: Tasfaout, Hichem, et al.
Publicado: (2018)

Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
por: Gómez-Oca, Raquel, et al.
Publicado: (2021)

Extensive morphological and immunohistochemical characterization in myotubular myopathy
por: Shichiji, Minobu, et al.
Publicado: (2013)

Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy
por: Biancalana, Valérie, et al.
Publicado: (2018)

Natural history study and statistical modeling of disease progression in a preclinical model of myotubular myopathy
por: Buono, Suzie, et al.
Publicado: (2022)

Myostatin: a Circulating Biomarker Correlating with Disease in Myotubular Myopathy Mice and Patients
por: Koch, Catherine, et al.
Publicado: (2020)

Effect of PGC1-beta ablation on myonuclear organisation
por: Beedour, Ryan, et al.
Publicado: (2019)

Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy
por: Gayi, Elinam, et al.
Publicado: (2018)

Respiratory care in myotubular myopathy
por: Tan, Hui-leng, et al.
Publicado: (2021)

Manifesting carriers of X-linked myotubular myopathy: Genetic modifiers modulating the phenotype
por: Souza, Lucas Santos, et al.
Publicado: (2020)

Arrhythmias in patients with X-linked myotubular myopathy
por: Pons-Espinal, Marina, et al.
Publicado: (2023)

Integrative Data Mining Highlights Candidate Genes for Monogenic Myopathies
por: Neto, Osorio Abath, et al.
Publicado: (2014)

Tamoxifen therapy in a murine model of myotubular myopathy
por: Maani, Nika, et al.
Publicado: (2018)

Inactivating the lipid kinase activity of PI3KC2β is sufficient to rescue myotubular myopathy in mice
por: Massana-Muñoz, Xènia, et al.
Publicado: (2023)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)

Physiological impact and disease reversion for the severe form of centronuclear myopathy linked to dynamin
por: Muñoz, Xènia Massana, et al.
Publicado: (2020)

X-linked recessive myotubular myopathy with MTM1 mutations
por: Han, Young-Mi, et al.
Publicado: (2013)

A natural history study of X-linked myotubular myopathy
por: Amburgey, Kimberly, et al.
Publicado: (2017)

Estimation of the Quality-of-Life Impact of X-Linked Myotubular Myopathy
por: Lloyd, Andrew, et al.
Publicado: (2021)

Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons
por: Lawlor, Michael W., et al.
Publicado: (2016)

Antagonistic control of active surface integrins by myotubularin and phosphatidylinositol 3-kinase C2β in a myotubular myopathy model
por: Samsó, Paula, et al.
Publicado: (2022)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
por: Osting, Sue, et al.
Publicado: (2014)

Clinical Phenotype of X‐Linked Myotubular Myopathy in Labrador Retriever Puppies
por: Snead, E.C.R., et al.
Publicado: (2015)

Natural history of a mouse model of X-linked myotubular myopathy
por: Sarikaya, Ege, et al.
Publicado: (2022)

AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis
por: Buj-Bello, Anna, et al.
Publicado: (2008)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020)

Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy
por: Karolczak, Sophie, et al.
Publicado: (2023)

Frequency and Phenotype of Myotubular Myopathy Amongst Danish Patients with Congenital Myopathy Older than 5 Years
por: Werlauff, U., et al.
Publicado: (2015)

Inflammatory myopathies: an update for neurologists
por: Silva, André Macedo Serafim, et al.
Publicado: (2022)

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
por: Bieber, Scott, et al.
Publicado: (2013)

rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021)

Loss of Myotubularin Function Results in T-Tubule Disorganization in Zebrafish and Human Myotubular Myopathy
por: Dowling, James J., et al.
Publicado: (2009)

Two Cases of X-Linked Myotubular Myopathy with Novel MTM1 Mutations
por: Lee, Eun Hye, et al.
Publicado: (2013)

X-linked myotubular myopathy and recurrent spontaneous pneumothorax: A new phenotype?
por: Carstens, Per-Ole, et al.
Publicado: (2019)

X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition
por: Volpatti, Jonathan R., et al.
Publicado: (2022)

Impairments in contractility and cytoskeletal organisation cause nuclear defects in nemaline myopathy
por: Ross, Jacob A., et al.
Publicado: (2019)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
por: Chu, Wing Sum, et al.
Publicado: (2021)

Monobac System–A Single Baculovirus for the Production of rAAV
por: Galibert, Lionel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16cek843frfkbf8ivjdj1mr7hm